Latest Research
- Alzamend Seeks FDA Approval to Test Alzheimer’s Dementia Vaccine: ALZN002 is designed to harness patient’s immune system to remove amyloid-beta
by Patricia Inacio, PhD
Alzheimer’s News Today, 2022 Oct 25 - Overcoming Insomnia with Tart Cherry Juice
by Terry Graedon, PhD
The People’s Pharmacy, 2022 Oct 24 - Using Communication Accommodation Theory to Improve Communication Between Healthcare Providers and Persons with Dementia
by Beheshta Momand, Olivia Sacuevo, Masuoda Hamidi, Winnie Sun, Adam Dubrowski
Cureus, 2022 Oct 23 - When Speech is Gone: A Method for Nonverbal Communication in Dementia
By Elizabeth Hewitt
Being Patient, 2022 Oct 10 - Supplementation with Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer’s Disease
by Nolan JM, Power R, Howard AN, Bergin P, Roche W, Prado-Cabrero A, Pope G, Cooke J, Power T, Mulcahy R.
J Alzheimers Dis. 2022 Sep 9. doi: 10.3233/JAD-220556. Online ahead of print. PMID: 36093704 - Improved Screening for Post-op Delirium Holds Promise
by Marcus A. Banks
Medscape.com, 2022 Sep 27 - Too Much TV Time Could Mean a Higher Risk of Dementia
by Miguel Ángel Criado
El País, 2022 Aug 23 - Leisure-time Sedentary Behaviors are Differentially Associated with All-cause Dementia Regardless of Engagement in Physical Activity
by David A. Raichlen, Yann C. Klimentidis, M. Katherine Sayre, Pradyumna K. Bharadwaj, Mark H. C. Lai, Rand R. Wilcox, Gene E. Alexander
Proceedings of the National Academy of Sciences of the United States of America, 2022 Aug 22